Conference abstractPublished 14 Nov 2016
ENPP1-Fc inhibits proliferation of vascular smooth muscle cells
Alexion Pharmaceuticals, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vascular smooth muscle cell (VSMCs) proliferation-associated stenosis is a major hallmark in the pathogenesis of Generalized Arterial Calcification of Infancy (GACI), an ultra-rare disease associated with ENPP1 loss of function mutations in the majority of patients. ENPP1 is an ectonucleotide pyrophosphatase that hydrolyzes ATP and serves as a key regulator of bone mineralization, however, the role that ENPP1 plays in intimal proliferation is poorly understood. Knockout mice lacking ENPP1 do not recapitulate the phenotype of intimal thickening, a common pathological feature in most GACI patients. Here, we examined the impact of ENPP1 on proliferation of primary rat VSMCs. Silencing ENPP1 using siRNA led to a significant increase in proliferation of VSMCs relative to that of cells transfected with negative control siRNA. This increased proliferation was inhibited by over expression of ENPP1 using an adenoviral vector encoding mouse ENPP1cDNA. Treatment of VSMCs with the ENPP1- reaction products AMP or Adenosine resulted in moderate inhibition of VSMC proliferation, while treatment with the ENPP1-Fc fusion protein inhibited VSMC proliferation significantly. In contrast, neither addition of bisphosphonates, a current off-label treatment used for GACI, nor inorganic pyrophosphate (PPi) affected proliferation of VSMCs. In summary, using both loss of function and gain of function approaches, we demonstrated that ENPP1 negatively regulates VSMC proliferation, and that ENPP1-Fc protein replacement is effective in inhibiting proliferation associated with loss of ENPP1 in VSMCs. These findings suggest that ENPP1 enzyme replacement may serve as a potential therapeutic approach for treating myointimal proliferation in GACI disease.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- BylineArticles whose byline prints “Yan Yan”